These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 21981954)

  • 1. Strategies for maximizing growth in puberty in children with short stature.
    Mauras N
    Pediatr Clin North Am; 2011 Oct; 58(5):1167-79, x. PubMed ID: 21981954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategies for maximizing growth in puberty in children with short stature.
    Mauras N
    Endocrinol Metab Clin North Am; 2009 Sep; 38(3):613-24. PubMed ID: 19717007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Letrozole significantly improves growth potential in a pubertal boy with growth hormone deficiency.
    Zhou P; Shah B; Prasad K; David R
    Pediatrics; 2005 Feb; 115(2):e245-8. PubMed ID: 15653791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of aromatase inhibitors in children and adolescents: what's new?
    Diaz-Thomas A; Shulman D
    Curr Opin Pediatr; 2010 Aug; 22(4):501-7. PubMed ID: 20489637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency.
    Högler W; Briody J; Moore B; Lu PW; Cowell CT
    Bone; 2005 Nov; 37(5):642-50. PubMed ID: 16139578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of aromatase inhibitors in children and adolescents with disorders of growth and adolescent development.
    Shulman DI; Francis GL; Palmert MR; Eugster EA;
    Pediatrics; 2008 Apr; 121(4):e975-83. PubMed ID: 18381525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of idiopathic short stature: effects of gonadotropin-releasing hormone analogs, aromatase inhibitors and anabolic steroids.
    Dunkel L
    Horm Res Paediatr; 2011; 76 Suppl 3():27-9. PubMed ID: 21912156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vertebral morphology in aromatase inhibitor-treated males with idiopathic short stature or constitutional delay of puberty.
    Hero M; Toiviainen-Salo S; Wickman S; Mäkitie O; Dunkel L
    J Bone Miner Res; 2010 Jul; 25(7):1536-43. PubMed ID: 20200972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of puberty in growth hormone deficient children.
    Saggese G; Federico G; Barsanti S
    J Pediatr Endocrinol Metab; 1999 Apr; 12 Suppl 1():329-34. PubMed ID: 10698597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of aromatase inhibitor therapy on bone turnover, cortical bone growth and vertebral morphology in pre- and peripubertal boys with idiopathic short stature.
    Hero M; Mäkitie O; Kröger H; Nousiainen E; Toiviainen-Salo S; Dunkel L
    Horm Res; 2009; 71(5):290-7. PubMed ID: 19339794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Approach to the Peripubertal Patient With Short Stature.
    Torres-Santiago L; Mauras N
    J Clin Endocrinol Metab; 2024 Jun; 109(7):e1522-e1533. PubMed ID: 38181434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternatives in the Treatment of Short Stature.
    Lanes R; González Briceño LG
    Adv Pediatr; 2017 Aug; 64(1):111-131. PubMed ID: 28688585
    [No Abstract]   [Full Text] [Related]  

  • 13. Should Skeletal Maturation Be Manipulated for Extra Height Gain?
    Wit JM
    Front Endocrinol (Lausanne); 2021; 12():812196. PubMed ID: 34975773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of short stature with GnRH agonist and co-treatment with growth hormone: a controversial issue.
    Carel JC
    Mol Cell Endocrinol; 2006 Jul; 254-255():226-33. PubMed ID: 16787697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on the role of aromatase inhibitors in growth disorders.
    Dunkel L
    Horm Res; 2009 Jan; 71 Suppl 1():57-63. PubMed ID: 19153508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel approaches to short stature therapy.
    Wit JM; Oostdijk W
    Best Pract Res Clin Endocrinol Metab; 2015 Jun; 29(3):353-66. PubMed ID: 26051296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of Growth Disorders in Puberty: GH, GnRHa, and Aromatase Inhibitors: A Clinical Review.
    Mauras N; Ross J; Mericq V
    Endocr Rev; 2023 Jan; 44(1):1-13. PubMed ID: 35639981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined use of growth hormone and gonadotropin-releasing hormone analogues: the national cooperative growth study experience.
    Kohn B; Julius JR; Blethen SL
    Pediatrics; 1999 Oct; 104(4 Pt 2):1014-8. PubMed ID: 10506254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Letrozole vs anastrozole for height augmentation in short pubertal males: first year data.
    Neely EK; Kumar RB; Payne SL; Ranadive SA; Suchet DI
    J Clin Endocrinol Metab; 2014 Nov; 99(11):4086-93. PubMed ID: 25137428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of manipulation of puberty on growth.
    Lee PA
    Horm Res; 2003; 60(Suppl 1):60-7. PubMed ID: 12955020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.